Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma: A Single-arm Phase 2 Trial

NCT04678362 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT04678362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04678362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma: A Single-arm Phase 2 Trial
Lead sponsor
Centre Francois Baclesse
Phase
Phase 2
Overall status
Recruiting
Start date
June 1, 2021
Completion date
December 31, 2025
Enrollment
50 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

urothelial carcinoma